Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 16, No 4 (2023) Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova
"... of effective and safe nephroprotective agents. Human placenta hydrolysates (HPH) are hepatoprotectors ..."
 
Vol 17, No 4 (2024) Study of the effect of human placenta hydrolysate in a new model of metabolic-associated fatty liver disease with iron overload Abstract  similar documents
T. E. Bogacheva, O. A. Gromova, I. Yu. Torshin, V. I. Demidov, A. G. Kalacheva, A. A. Garanin, I. V. Gogoleva, L. E. Fedotova, O. A. Limanova, А. N. Mnatsakanyan, N. Yu. Zhidomorov, T. R. Grishina
"... of using human placenta hydrolyzate (HPH) in experiment. Material and methods. In experiment, the rats ..."
 
Vol 16, No 3 (2023) An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis Abstract  similar documents
M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova
"... Objective: to evaluate the efficacy and safety of human placenta hydrolysate (HPH) Laennec ..."
 
Vol 14, No 4 (2021) Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy Abstract  similar documents
I. Yu. Torshin, О. А. Gromova, V. G. Zgoda, А. G. Chuchalin, V. А. Maksimov, О. V. Tikhonova
"... Objective: identification of peptides in the composition of Laennec®, which can inhibit ..."
 
Vol 13, No 4 (2020) Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, V. A. Maksimov, A. G. Chuchalin, V. G. Zgoda, А. N. Gromov, O. V. Tikhonova
"... deposits in tissues. Aim. The study was aimed to identify peptides contained in the composition ..."
 
Vol 18, No 1 (2025) Clinical and diagnostic significance of isolated detection of IgA antibodies to deamidated gliadin peptides in IgA nephropathy patients Abstract  similar documents
M. E. Mantsaeva, D. I. Korabelnikov, A. G. Borisov
"... antigens, such as gluten. Patients with IgAN often have IgA antibodies to deamidated gliadin peptides ..."
 
Vol 16, No 3 (2023) The role of ferritin in liver disease assessment Abstract  similar documents
V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik
"... of peptide components of human placenta hydrolysate (Laennec®) impact on pathophysiological processes ..."
 
Vol 17, No 4 (2024) Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment Abstract  similar documents
S. К. Zyryanov, I. N. Dyakov
"... of alogliptin-pioglitazone combination versus glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Material ..."
 
Vol 16, No 3 (2023) Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. N. Gromov
"... lipid-lowering, hepatoprotective, nephroprotective, anti-asthenic, cardioprotective, and neuroprotective ..."
 
Online First Osteoarthritis therapy misconcepts Abstract  similar documents
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov
"... on bioactive concentrate of small sea fish and glycoaminoglycan-peptide complex do not belong to SYSADOAs ..."
 
Vol 16, No 2 (2023) From misconceptions to reasonable osteoarthritis patients therapy Abstract  similar documents
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov
"... and glycoaminoglycan-peptide complex do not belong to SYSADOAs according to any of the existing generally recognized ..."
 
Vol 12, No 4 (2019) Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis Abstract  similar documents
I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva
"... substance-glycosaminoglycan-peptide complex (Romania), on the 1st day – 0.3 ml, on the 2nd day – 0.5 ml ..."
 
Vol 17, No 2 (2024) Chemoreactomic study of fonturacetam effects: molecular mechanisms of influence on adipose tissue metabolism Abstract  similar documents
O. A. Gromova, I. Yu. Torshin
"... -adrenoceptors, adenosine receptors, glucagon-like peptide, sphingosine phosphate and peroxisome proliferators ..."
 
Vol 15, No 3 (2022) Long-term analysis of сanagliflozin budget impact in adult patients with type 2 diabetes mellitus and diabetic nephropathy in the Russian Federation Abstract  similar documents
N. A. Avxentyev, Yu. V. Makarova
"... state procurement of SGLT2 inhibitors and glucagon-like peptide-1 receptor agonists in 2021, we ..."
 
1 - 15 of 15 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)